PMID- 15257044 OWN - NLM STAT- MEDLINE DCOM- 20040817 LR - 20190713 IS - 0041-1337 (Print) IS - 0041-1337 (Linking) VI - 78 IP - 1 DP - 2004 Jul 15 TI - Assessment of optimal size and composition of the U.S. National Registry of hematopoietic stem cell donors. PG - 89-95 AB - BACKGROUND: The National Marrow Donor Program (NMDP) receives federal funding to operate a registry of over 4 million volunteer donors for patients in need of a hematopoietic stem cell transplant. Because minority patients are less likely to find a suitably matched donor than whites, special efforts have been aimed toward recruitment of minorities. Significant financial resources are required to recruit and tissue type additional volunteer donors. METHODS: Population genetics models have been constructed to project likelihoods of finding a human leukocyte antigen (HLA)-matched donor for patients of various racial/ethnic groups. These projections have been made under a variety of strategies for expansion of the NMDP Registry. Cost-effectiveness calculations incorporated donor unavailability and other barriers to transplantation. RESULTS: At current recruitment rates, the probability of an available HLA-A,B,DRB1 matched donor is projected to increase from 27% to 34%; 45% to 54%; 75% to 79%; and 48% to 55%, for blacks, Asians/Pacific Islanders, whites and Hispanics, respectively, by the year 2007. Substantial increases in minority recruitment would have only modest impacts on these projections. These projections are heavily affected by donor availability rates, which are less than 50% for minority volunteers. CONCLUSIONS: Continued recruitment of additional volunteers can improve the likelihood of finding an HLA-matched donor, but will still leave significant numbers of patients of all racial/ethnic groups without a match. Efforts to improve donor availability (especially among minorities) and to increase the number of patients with access to the NMDP Registry may prove to be more cost-effective means of increasing transplants. FAU - Kollman, Craig AU - Kollman C AD - National Marrow Donor Program, Minneapolis, MN, USA. ckollman@jaeb.org FAU - Abella, Esteban AU - Abella E FAU - Baitty, Robert L AU - Baitty RL FAU - Beatty, Patrick G AU - Beatty PG FAU - Chakraborty, Ranajit AU - Chakraborty R FAU - Christiansen, Cindy L AU - Christiansen CL FAU - Hartzman, Robert J AU - Hartzman RJ FAU - Hurley, Carolyn Katovich AU - Hurley CK FAU - Milford, Edgar AU - Milford E FAU - Nyman, John A AU - Nyman JA FAU - Smith, Thomas J AU - Smith TJ FAU - Switzer, Galen E AU - Switzer GE FAU - Wada, Randal K AU - Wada RK FAU - Setterholm, Michelle AU - Setterholm M LA - eng GR - HS 240-97-0036/HS/AHRQ HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, Non-P.H.S. PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Transplantation JT - Transplantation JID - 0132144 SB - IM MH - Genetics, Population MH - *Hematopoietic Stem Cell Transplantation MH - Histocompatibility Testing MH - Humans MH - Public Policy MH - Registries/*statistics & numerical data MH - Tissue Donors/*statistics & numerical data MH - United States EDAT- 2004/07/17 05:00 MHDA- 2004/08/18 05:00 CRDT- 2004/07/17 05:00 PHST- 2004/07/17 05:00 [pubmed] PHST- 2004/08/18 05:00 [medline] PHST- 2004/07/17 05:00 [entrez] AID - 00007890-200407150-00015 [pii] AID - 10.1097/01.tp.0000132327.40702.97 [doi] PST - ppublish SO - Transplantation. 2004 Jul 15;78(1):89-95. doi: 10.1097/01.tp.0000132327.40702.97.